Company Comparison
TreeFrog Therapeutics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | TreeFrog Therapeutics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Bordeaux, France | Lagos, Nigeria |
| Founded | 2018 | 2019 |
| Status | Active | Active |
| Last Funding Stage | Series B | Series B |
| Total Funding | $82M | $45M |
| Valuation | — | — |
What They Build
TreeFrog Therapeutics
Biotech company developing scalable cell therapy manufacturing technologies using innovative 3D cell culture and microcarrier systems.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
TreeFrog Therapeutics
Sector Overlap
Both TreeFrog Therapeutics and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.